Tenet Healthcare Corp. Files Definitive Proxy Statement

Ticker: THC · Form: DEF 14A · Filed: Apr 12, 2024 · CIK: 70318

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Tenet Healthcare, Executive Compensation, Corporate Governance

TL;DR

<b>Tenet Healthcare Corp. has filed its Definitive Proxy Statement for the period ending May 22, 2024.</b>

AI Summary

TENET HEALTHCARE CORP (THC) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. Tenet Healthcare Corp. filed a Definitive Proxy Statement (DEF 14A) on April 12, 2024. The filing covers the period ending May 22, 2024. The company's principal executive offices are located at 14201 Dallas Parkway, Dallas, TX 75254. Tenet Healthcare Corp. was formerly known as National Medical Enterprises Inc. /NV/. The filing includes data related to executive compensation and equity awards for the fiscal year ending December 31, 2023.

Why It Matters

For investors and stakeholders tracking TENET HEALTHCARE CORP, this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation, board nominations, and other corporate governance matters before the annual meeting. Shareholders can use this information to make informed voting decisions on proposals presented by the company and potentially by shareholders.

Risk Assessment

Risk Level: low — TENET HEALTHCARE CORP shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate governance disclosures rather than immediate financial or operational concerns.

Analyst Insight

Review the executive compensation details and any shareholder proposals to inform voting decisions for the upcoming annual meeting.

Key Numbers

Key Players & Entities

FAQ

When did TENET HEALTHCARE CORP file this DEF 14A?

TENET HEALTHCARE CORP filed this Proxy Statement (DEF 14A) with the SEC on April 12, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by TENET HEALTHCARE CORP (THC).

Where can I read the original DEF 14A filing from TENET HEALTHCARE CORP?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by TENET HEALTHCARE CORP.

What are the key takeaways from TENET HEALTHCARE CORP's DEF 14A?

TENET HEALTHCARE CORP filed this DEF 14A on April 12, 2024. Key takeaways: Tenet Healthcare Corp. filed a Definitive Proxy Statement (DEF 14A) on April 12, 2024.. The filing covers the period ending May 22, 2024.. The company's principal executive offices are located at 14201 Dallas Parkway, Dallas, TX 75254..

Is TENET HEALTHCARE CORP a risky investment based on this filing?

Based on this DEF 14A, TENET HEALTHCARE CORP presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating standard corporate governance disclosures rather than immediate financial or operational concerns.

What should investors do after reading TENET HEALTHCARE CORP's DEF 14A?

Review the executive compensation details and any shareholder proposals to inform voting decisions for the upcoming annual meeting. The overall sentiment from this filing is neutral.

How does TENET HEALTHCARE CORP compare to its industry peers?

Tenet Healthcare Corporation operates as a healthcare services company, primarily focused on hospital operations.

Are there regulatory concerns for TENET HEALTHCARE CORP?

This filing is a standard DEF 14A, which is a regulatory requirement for public companies to disclose information related to shareholder meetings and corporate governance.

Industry Context

Tenet Healthcare Corporation operates as a healthcare services company, primarily focused on hospital operations.

Regulatory Implications

This filing is a standard DEF 14A, which is a regulatory requirement for public companies to disclose information related to shareholder meetings and corporate governance.

What Investors Should Do

  1. Review the proxy statement for details on director nominees and their qualifications.
  2. Analyze the executive compensation section to understand pay structures and performance metrics.
  3. Examine any shareholder proposals and the company's recommendations for voting.

Key Dates

Year-Over-Year Comparison

This is the initial filing of the DEF 14A for the current reporting period.

Filing Stats: 4,409 words · 18 min read · ~15 pages · Grade level 13.1 · Accepted 2024-04-12 16:31:33

Filing Documents

Executive Compensation Tables

Executive Compensation Tables 58 2023 Summary Compensation Table 58 Grants of Plan-Based Awards During 2023 60 Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table 61 Outstanding Equity Awards 62 Option Exercises and Stock Vested 64 Pension Benefits 64 Nonqualified Deferred Compensation 66 Potential Payments Upon Termination or Change of Control 67 Pay Ratio Disclosure 73 Pay Versus Performance 74 Securities Authorized for Issuance Under Equity Compensation Plans 77 Equity Compensation Plan Information 77 Proposal 2 - Advisory Vote to Approve Executive Compensation 78 Audit Committee Report 79 Proposal 3 - Ratification of the Selection of Independent Registered Public Accountants 81 Proposal 4 - Shareholder Proposal – Report on Risk Mitigation Regarding State Restrictions for Emergency Abortions 82 Proposal 5 - Shareholder Proposal – Report on Plans to Integrate ESG Metrics Into Executive Compensation 84 General Information Regarding the Annual Meeting and Voting 86 Other Information 90 Appendix A: Non-GAAP Financial Measures A-1 This Proxy Statement includes certain financial measures not in accordance with generally accepted accounting principles in the United States (GAAP), such as Adjusted EBITDA, Adjusted Free Cash Flow and Adjusted EPS. Definitions of these measures are contained in Appendix A to this Proxy Statement. Table of Contents Proxy Statement Summary Below are highlights of certain information in this Proxy Statement. Please refer to the complete Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2023 before you vote. 2024 ANNUAL MEETING OF SHAREHOLDERS Date and Time: Wednesday, May 22, 2024, at 8:00 a.m. Central Time Place: Online by registering at www.proxydocs.com/THC Record Date: March 27, 2024 Information: The Notice of Internet Availability, this Proxy Statement and relate

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing